InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,470.78
(
0.21%
)
US TECH 100
18,652.80
(
0.72%
)
Dow Jones
40,565.24
(
-0.06%
)
Brent Oil
78.78
(
-2.23%
)
Bitcoin
66,897.45
(
-1.33%
)
Post# of 427318
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Biobillionair

Send PM Follow Ignore
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Biobillionair

Re: None

Monday, 06/10/2013 8:48:39 AM

Monday, June 10, 2013 8:48:39 AM

Post# of 427318
New Administrative Document(s) & Correspondence under Lovaza/Omacor review. It appears the FDA granted 5 yrs of NCE without an exclusivity request. Interesting?!

http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-654_Omacor.cfm

Part one

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM

INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM

BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM

Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM

Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM

Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!